Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-10T07:25:11.405Z Has data issue: false hasContentIssue false
  • English
  • Français

Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics

Published online by Cambridge University Press:  16 April 2020

J.-P. Czerny ,
P. Briken  and
W. Berner
J.-P. Czerny
Affiliation:
Department of Sexology (Director: Prof. Dr. W. Berner), Clinic of Psychiatry and Psychotherapy of the University of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany
P. Briken*
Affiliation:
Department of Sexology (Director: Prof. Dr. W. Berner), Clinic of Psychiatry and Psychotherapy of the University of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany
W. Berner
Affiliation:
Department of Sexology (Director: Prof. Dr. W. Berner), Clinic of Psychiatry and Psychotherapy of the University of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany
*
*Correspondence and reprints. E-mail address: briken@uke.uni-hamburg.de (P. Briken).
Get access

Summary

The aim of this study was to investigate which antihormonal treatment strategies are used in German forensic psychiatric institutions. Forensic clinics were asked about the number of treated patients. Four hundred seventy-four patients were committed for sex offences; 12% received either CPA (n = 29) or LHRH- agonists (n = 29). Differences in efficacy were small. Several side effects confirm the importance of a protocol for minimizing medical complications.

Keywords

cyproterone acetateforensic psychiatryGnRH-agonistsLHRH-agonistsparaphilia
Type
Short communication
Information
European Psychiatry , Volume 17 , Issue 2 , April 2002 , pp. 104 - 106
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS. 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Briken, PBerner, WNoldus, JNika, EMichl, U. Therapy of paraphilia with LHRH-agonists. WPA-Abstract, XI World Congress of Psychiatry. Curr Opin Psychiatry 1999 ; 12 (Suppl 1) : 150.Google Scholar
Briken, PBerner, WNoldus, JNika, EMichl, U. Therapie mit dem LHRH-Agonisten Leuprorelinacetat bei Paraphilien* und sexuelll aggressiven Impulshhandlungen. Nervenarzt 2000 ; 71 : 380–5.CrossRefGoogle Scholar
Briken, PNika, EBerner, W. Treatment of paraphilia with luteinizing hormone-releasing hormone agonists. J Sex Marital Ther 2001 ; 27 : 45–55.Google ScholarPubMed
Cooper, AJCernowsky, Z. Comparison of cyproterone acetate (CPA) and leuprolide acetate (LHRH agonist) in a chronic pedophile: a clinical case study. Biol Psychiatry 1994 ; 36 : 269–71.CrossRefGoogle Scholar
Dickey, R. The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist. Can J Psychiatry 1992 ; 37 : 567–9.CrossRefGoogle ScholarPubMed
Reilly, DRDelva, NJHudson, RW. Protocols of the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia. Can J Psychiatry 2000 ; 45 : 559–63.CrossRefGoogle ScholarPubMed
Rösler, AWitztum, E. Treatment of men with paraphilia with long-acting analogue of gonadotropin-releasing hormone. N Engl J Med 1998 ; 338 : 416–22.CrossRefGoogle ScholarPubMed
Rösler, AWitztum, E. Pharmacotherapy of paraphilias in the next millennium. Behav Sci Law 2000 ; 18 : 43–56.3.0.CO;2-8>CrossRefGoogle ScholarPubMed
Rousseau, LCouture, MDupont, ALabrie, FCouture, N. Effect of combined androgen blockade with an LHRH agonist and flutamine in one severe case of male exhibitionism. Can J Psychiatry 1990 ; 35 : 338–41.CrossRefGoogle Scholar
Thibaut, FCordier, BKuhn, JM. Gonadotropin hormone releasing hormone agonist in cases of severe paraphilia: a lifetime treatment? Psychoneuroendocrinology 1996 ; 21 : 411–9.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.